MentionFox
Home › Stakes › DataMeds AI, Inc.
5%+ stakes · Schedule 13D and 13G

DataMeds AI, Inc.: 5%+ holders

Before you sign with, sell to or invest in DataMeds AI, Inc.

MentionFox check on DataMeds AI, Inc.: only 1 source on file so far (checked 16 November 2026). Run a full check before you rely on it. mentionfox.com/c/stakes/datameds-ai

Check DataMeds AI, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about DataMeds AI, Inc.?

Who has reported owning 5% or more of DataMeds AI, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

As of November 16, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of DataMeds AI, Inc. The largest reported stake is Hyperscale Data, Inc.'s, at 9.99%. One filing is on record since November 10, 2026 (Schedule 13G, November 10, 2026).

Hyperscale Data, Inc. also filed stake reports on 4 other companies ↓

Sell to companies like DataMeds AI, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

  • · Reporting person: Hyperscale Data, Inc. · Sole voting: 0 · Shared voting: 501,204 · Sole dispositive: 0 · Shared dispositive: 501,204 · SCHEDULE 13G, 2026-11-10
  • · Holder: Hyperscale Data, Inc. · Percent: 9.99% · SCHEDULE 13G
  • · Holder: Hyperscale Data, Inc. · Percent: 9.99% · Shares: 501,204 · SCHEDULE 13G
At 5% or more1
Filings1
Latest filing2026-11-10

DataMeds AI, Inc. has 1 Schedule 13D or 13G filing on record since 2026-11-10. 1 holder's latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Hyperscale Data, Inc.9.99%501,204SCHEDULE 13G, 2026-11-102026-05-27

Holding shares or following this stake? See who's behind DataMeds AI, Inc. and the warning signs.

Free to see. No signup.

Keep reading

More on DataMeds AI, Inc. and the records around it.

DataMeds AI, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on DataMeds AI, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on DataMeds AI, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on DataMeds AI, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Hyperscale Data, Inc.0501,2040501,204SCHEDULE 13G, 2026-11-10

The latest filing identifies DataMeds AI, Inc. by CUSIP 949503205 and gives its principal executive office as 3000 Bayport Drive, Suite 950, Tampa, FL 33607 (SCHEDULE 13G, 2026-11-10).

Timeline

FiledHolderPercentFiling
2026-11-10Hyperscale Data, Inc.9.99%SCHEDULE 13G

Also on the record for DataMeds AI, Inc.

DateRecordFigureOur pageSource
November 10, 2026IPO filing, Form S-1/A—IPO filingsSource
October 9, 2026IPO filing, Form S-1/A—IPO filingsSource
August 7, 2026IPO filing, Form S-1—IPO filingsSource
February 9, 2026Leadership change: Gary Herman appointed, Director—Leadership changesSource
February 5, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
September 29, 2025IPO filing, Form 424B4$0.7 a shareIPO filingsSource
September 22, 2025IPO filing, Form S-1/A—IPO filingsSource
September 12, 2025IPO filing, Form S-1/A—IPO filingsSource
August 29, 2025IPO filing, Form S-1/A—IPO filingsSource
July 24, 2025IPO filing, Form S-1—IPO filingsSource
May 5, 2025IPO filing, Form S-1—IPO filingsSource
February 21, 2025IPO filing, Form 424B4$4.5 a shareIPO filingsSource

The newest 12 of 20 records.

Tools for this story

Each opens in a new tab, filled in for DataMeds AI, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/datameds-ai
Last updated 2026-11-16
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Who owns 5% or more of DataMeds AI, Inc.? 1 holder at 5% or more, largest Hyperscale Data, Inc. 9.99%. MentionFox, 2026-11-16. https://mentionfox.com/stakes/datameds-ai